Skip to main content
ALLO filings

Corporate insider profile

Earl Martin Douglas Filing Activity

Latest reported as SVP, General Counsel of Allogene Therapeutics, Inc. (ALLO).

Purchase filings
0
Reported companies
1
Net open-market value
-$62,957.64
Latest transaction
Aug 21, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 21, 2026Allogene Therapeutics, Inc. (ALLO)SVP, General CounselSale29,697$2.12$62,958